Innovent bio insulin aspart patent?

Do you mean Innovent Biologics’ insulin aspart (e.g., sold in certain markets) and you want the relevant patent(s)?

I can help, but “Innovent bio insulin aspart patent” is a bit broad. Patents depend heavily on which country/region (CN, US, EP, etc.) and the exact product form (e.g., NovoLog/Fiasp-style insulin aspart, injection concentration, formulation, device, or manufacturing process).

Quick clarifying questions (so I can point you to the right patents)

1. Which jurisdiction do you care about? (China / US / Europe / World)
2. Are you looking for compound (insulin aspart) patents, or formulation/manufacturing/device patents?
3. Do you have a product name/label strength (e.g., U-100, “Fiasp-like”, cartridge/pen/vial) or a link/approval page?

Important context (why this gets tricky)

• Insulin aspart itself originated from Novo Nordisk (rapid-acting insulin aspart). Many foundational patents are old and may have expired depending on the country.
• What companies like Innovent may hold are often later patents for:
  • formulation improvements,
  • stability/solubility,
  • manufacturing/analytical processes,
  • patents specific to biosimilar/biobetter versions,
  • packaging/combination claims,
  • local regulatory filings that cite certain patent families.

If you reply with the country + any product details

…I can search the right patent families and summarize:

• patent numbers
• assignees/applicants
• key claims (what is actually covered)
• status (granted vs. pending, and typical expiration windows)

Just tell me: China or US? and any product name you’re referring to.